Cargando…
Impacto de la pandemia SARS-CoV-2 en el inicio de las prescripciones
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
FECA. Published by Elsevier España, S.L.U.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522796/ https://www.ncbi.nlm.nih.gov/pubmed/33115612 http://dx.doi.org/10.1016/j.jhqr.2020.09.001 |
_version_ | 1783588258150612992 |
---|---|
author | Mendizabal Olaizola, A. Valverde Bilbao, E. |
author_facet | Mendizabal Olaizola, A. Valverde Bilbao, E. |
author_sort | Mendizabal Olaizola, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7522796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | FECA. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75227962020-09-29 Impacto de la pandemia SARS-CoV-2 en el inicio de las prescripciones Mendizabal Olaizola, A. Valverde Bilbao, E. J Healthc Qual Res Cartas a La Directora FECA. Published by Elsevier España, S.L.U. 2020 2020-09-29 /pmc/articles/PMC7522796/ /pubmed/33115612 http://dx.doi.org/10.1016/j.jhqr.2020.09.001 Text en © 2020 FECA. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Cartas a La Directora Mendizabal Olaizola, A. Valverde Bilbao, E. Impacto de la pandemia SARS-CoV-2 en el inicio de las prescripciones |
title | Impacto de la pandemia SARS-CoV-2 en el inicio de las prescripciones |
title_full | Impacto de la pandemia SARS-CoV-2 en el inicio de las prescripciones |
title_fullStr | Impacto de la pandemia SARS-CoV-2 en el inicio de las prescripciones |
title_full_unstemmed | Impacto de la pandemia SARS-CoV-2 en el inicio de las prescripciones |
title_short | Impacto de la pandemia SARS-CoV-2 en el inicio de las prescripciones |
title_sort | impacto de la pandemia sars-cov-2 en el inicio de las prescripciones |
topic | Cartas a La Directora |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522796/ https://www.ncbi.nlm.nih.gov/pubmed/33115612 http://dx.doi.org/10.1016/j.jhqr.2020.09.001 |
work_keys_str_mv | AT mendizabalolaizolaa impactodelapandemiasarscov2eneliniciodelasprescripciones AT valverdebilbaoe impactodelapandemiasarscov2eneliniciodelasprescripciones |